Trustees. Annual Report for the period Peri1 start date Pericrtj end date From To Section A Reference and administration details Charfty name Liver4Life Other names charity Is known by R•g16tered charlty numbor (If any) 1152618 Charlty's prlnclpal address Holme Cottage Croft Road Neacroft Postcode BH23 8JS Nam08 of tho charlty trustees who manage th• ¢harlty Dat•• •¢t•d 11 notlor ¥thol• Olllc•111 any) ar N•m• 01 p•rtt lor body) •ntitl•d toa Int tru8t•• If an Tru8t•• n•m• Richard Aspinall Sheila Connolly Elizabeth Wilson Alan Williams Chairperson 10 12 13 14 15 16 17 18 19 20 Names of the trustees for the charlty. If any, Ifor example. any custodlan trusteos) Name Dates acted If not for whole ear TAR Marth 2012
The ¢haTIty trustees confim Ihat they hav8 had regard to the guidance issued by Ihg Charity C<)mmi66ion on public benefit. and havo followed Ihis in planning and undertaking our activities. The tharity's aims are to support people affected by INer conditions through the provision of a variety of activities. The main activities undertaken in relation to our objects are: Continued delivery of'optimising Hep C Support. campaign to raise avrdreness of HCV and to offer inforrnation about associated risks via the medium of regional training sessions aimed at both people affected by HCV and those who engage with this community. Continued delivery of Auttrimmune condition support groups to enable both peers. carers and mentors to develop a better understsnding of aut&lmmune liver conditions and to build closer links within their communities Signpostsng other chanties, helplng organlsations and groups which support the needs of service us8ts. Ongoing development of a helpline and website to all people affected by liver I)ndItiOnS to access relevant inf0mtIOn Helpline available 5 days per week with specialist advice and signpostlng 6. Van work contlnued. and the van was used for outreach and community SUPPOrt during COVID uisis, we also stsrted YrkIng wlth University Hospital tk)rset for outreath to smaller more rural communili8s, indudir¥J FibroscanniTrJ Summary of th• maln actlvltles und•rtak•n for th• publ1¢ bonoflt In relatlon to thoso objocts (Includè wfthln thls s•ctlon the 8tatutory dgclaratlon that trustses hav• had rogard to the guldanc• Issued by the Charlty Comml•8lon on publlc b•noflt) You may choo•• to include further statements, where relevant, about: pollcy on grantmaklng. policy programme related investment; contribution made by volunteers. March 2012 TAR
Section D Achievements and performance Liver4Life {L4L), which set its initial goals as providing a free-phone helpline and developing infomiation to help the recently diagnosed and those affected by liver Conditions has continued to grow and develop. Continue to support 4 patient support groups The L4L van was a valuable asset in reaching communities during the continued lockdowns. We used the van to support palients who were vulnerable and shielding. Working with UHD to provide outreach into small8r rural communities. and we are planning outreach to homeless and at risk groups a¢ross the South of England. L4L did not attend any conferences this year. We are also working hard to build our social media profile. The managément team continue to create a strong brand and excellent aWaneSS to ensure L4L is identified as 8 very successful national liver charity- Clear goals and tsrgets have been developed jointly with the trustees and the management t8am. and with the implementation of these slrategies. L4L will Gonts'nue to grow and continue to be a key influencer with the liver community. The charitses work was undennined again this year with COVID, but continued to deliver on all services including the helpline and patient support groups. Summary of thè maln achievements of the charlty durlng the year Marth 2012 TAR
Section E Financial review The Trustees of Liver4Lrfe belleve that the Gharity should hold financial reseNes (the 'Emergency Operating Reserve. . EOR) because i. il has no endo%vni8nt fundlng and is entirely dèpendent for income upon donor funding from year to year which is inevitably subject to fluctuation and ii. it requires protection against. and the ability to continue operating despite, catsstrophic or lesser but damaging events The trustees believe that the minimum level of the EOR Should be the equivalent of six months. operab'ng costs calculated and reviewed annually and believe that the EOR should be built up to the desired level in stages consistent wth charty's overall financial position and Its need to maintain and devel its charitable activities. Brlaf statsmont of the ¢harlty'8 policy on re8erv•8 D•tall8 of any lunds matsrlalty In deflclt NIA Furthor flnanclal rnvlew d•lalls (Optlonal Informatlon) You may Ghoo•• to Include additional infomiation. where relevant about.. the charity's principal sources of funds (including any fundraislng): how expenditure has supported th8 kay obJ8Ctlves of the charity: Investrnent pollcy and obJectlv88 includlng any ethical investment pollcy adopted. Section F Other optional information M8fL* 2012
Section G Declaration The trustees declare that they have approved the trustees, report above. Signed on behalf of the charlty's truslees Slgnature{s) A'l Alan liams Full name(s) Posltlon (eg Secretary, Chalr, ètc) ard pir11 Chair of Tnjstees Trustee Dato Mar¢h 2012 TAR
| Liver4Life | Liver4Life | Liver4Life | 1152618 | CC16a | |
|---|---|---|---|---|---|
| Receipts andpayments accounts | |||||
| For the period from |
01/04/2021 | To | 31/03/2022 | ||
| Section A Receipts and payments | |||||
| A1 Receipts | Unrestricted funds to the nearest £ |
Restricted funds to the nearest £ |
Endowment funds to the nearest £ |
Total funds to the nearest £ |
Last year to the nearest £ |
Income |
16,445 | - | - | 16,445 | 41,370 |
| Friends of Liver Lifeline | - | 2 | - | 2 | 1,579 |
| - | - | - | - | - | |
| - | - | - | - | - | |
| - | - | - | - | - | |
| - | - | - | - | - | |
| - | - | - | - | - | |
| - | - | - | - | - | |
| Sub total(Gross income for AR) | 16,445 | 2 | - | 16,447 | 42,949 |
| A2 Asset and investment sales, (see table). |
|||||
| - | - | - | - | ||
| - | - | - | - | - | |
| Sub total | - | - | - | - | - |
| Total receipts A3 Payments |
|||||
| 16,445 | 2 | - | 16,447 | 42,949 | |
Not2Sexy- Project |
- | - | - | - | - |
| Office Equipment/Stationery | 348 | - | - | 348 | 947 |
| Van and Travel Expenses | 2,251 | 1,879 | - | 4,130 | 4,796 |
| Patient Support | 3,886 | - | - | 3,886 | 2,686 |
| Membership | - | - | - | - | - |
| I'm Worth It | - | - | - | - | - |
| Helpline | 12,055 | - | - | 12,055 | 5,194 |
| OptimisingHepC Support - Project | - | - | - | - | 3,683 |
| Fibroscan | 1,050 | - | - | 1,050 | - |
| Fundraising | 429 | - | - | 429 | - |
| **Sub total ** | 20,019 | 1,879 | - | 21,898 | 17,306 |
| A4 Asset and investment purchases, (see table) |
|||||
| Medical Equipment | - | - | - | - | - |
| TestingVan | - | - | - | - | 10,400 |
| **Sub total ** | - | - | - | - | 10,400 |
| Total payments Net of receipts/(payments) A5 Transfers between funds A6 Cash funds last year end Cash funds this year end |
|||||
| 20,019 | 1,879 | - | 21,898 | 27,706 | |
| - 3,574 | - 1,877 | - | - 5,451 | 15,243 | |
| - | - | - | - | - | |
| 10,475 | 2,123 | - | 12,598 | 10,475 | |
| 6,901 | 246 | - | 7,147 | 25,718 |
CCXX R1 accounts (SS)
31/01/2023
1
Section B Statement of assets and liabilities at the end of the period
| Categories Signed by one or two trustees on behalf of all the trustees B5 Liabilities B3 Investment assets B2 Other monetary assets B4 Assets retained for the charity’s own use B1 Cash funds |
Details | Unrestricted funds to nearest £ |
Restricted funds to nearest £ |
Endowment funds to nearest £ |
|---|---|---|---|---|
| Bank Accounts | 6,895 | - | - | |
| CAF Cash | - | - | - | |
| HCPC | - | - | - | |
| CAF Gold - FOLL | - | 246 | - | |
| Total cash funds | 6,895 | 246 | - | |
| (agree balances with receipts and payments account(s)) Details |
Agreement Error | OK | OK | |
| Unrestricted to nearest £ |
Restricted to nearest £ |
Endowment to nearest £ |
||
| - | - | - | ||
| - | - | - | ||
| - | - | - | ||
| - | - | - | ||
| - | - | - | ||
| - | - | - | ||
| Fund to which asset belongs |
Cost (optional) | Current value (optional) |
||
| Details | ||||
| - | - | |||
| - | - | |||
| - | - | |||
| - | - | |||
| - | - | |||
| Fund to which asset belongs |
Cost (optional) | Current value (optional) |
||
| Details | ||||
| - | - | |||
| - | - | |||
| - | - | |||
| - | - | |||
| - | - | |||
| - | - | |||
| - | - | |||
| - | - | |||
| - | - | |||
| Fund to which ~~liabilitrelates~~ |
Amount due ~~(otional)~~ |
When due ~~(otional)~~ |
||
| Details | ||||
| ~~y ~~ | ~~p~~ - |
~~p~~ | ||
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Signature | ||||
| Date of approval |
||||
CCXX R2 accounts (SS)
31/01/2023
2